Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma
Clinical trial NCT02656706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02656706
- Sponsor
- Brown University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.